Skip to main content
. 2011 Jan;13(1):1–11. doi: 10.1593/neo.101120

Table 1.

Potential PD Biomarkers for ALK SMI Treatment in NSCLC.

Symbol Entrez Gene Name Family Fold Change FDR Adjusted P value
AKT1 v-akt murine thymoma viral oncogene homolog 1 Kinase -3.23 2.48E-10
ATF1 Activating transcription factor 1 Transcription regulator -9.9 1.23E-10
CCNA2 Cyclin A2 Other -41.76 1.8E-13
CCNB1 Cyclin B1 Other -181.97 1.74E-17
CCNB2 Cyclin B2 Other -70.13 1.49E-17
CCNE2 Cyclin E2 Other -48.24 2.76E-16
CDC2 Cell division cycle 2, G1 to S and G2 to M Kinase -32.91 1.49E-17
CDK2 Cyclin-dependent kinase 2 Kinase -4.15 4.53E-12
CHEK1 CHK1 checkpoint homolog (Schizosaccharomyces pombe) Kinase -17.77 2.85E-11
EGFR Epidermal growth factor receptor Kinase -5.6 1.66E-10
H2AFX H2A histone family, member X Other -7.56 3.6E-15
HMGB2 High-mobility group box 2 Transcription regulator -8.3 2.88E-14
HRAS v-Ha-ras Harvey rat sarcoma viral oncogene homolog Enzyme -3.16 5.04E-09
IGFBP3 Insulin-like growth factor binding protein 3 Other -5.71 .00000303
IL8 Interleukin 8 Cytokine -8.4 1.97E-13
IL1R1 Interleukin 1 receptor, type I Transmembrane receptor -5.2 1.16E-11
IL1RAP Interleukin 1 receptor accessory protein Transmembrane receptor -18.67 .000848
IRS1 Insulin receptor substrate 1 Other -6.84 1.84E-11
KITLG KIT ligand Growth factor -4.77 1.03E-11
LMNB1 Lamin B1 Other -21.41 3.38E-15
MAP2K1 Mitogen-activated protein kinase kinase 1 Kinase -3.95 1.61E-11
MAP2K2 Mitogen-activated protein kinase kinase 2 Kinase -3.15 4.98E-08
MYC v-myc myelocytomatosis viral oncogene homolog Transcription regulator -5.59 5.3E-11
PCNA Proliferating cell nuclear antigen Other -5.98 4E-13
PLK1 Polo-like kinase 1 (Drosophila) Kinase -20.76 3.1E-14
SHC1 SHC (Src homolog 2 domain containing) transforming protein 1 Other -4.15 5.17E-12
TOP2A Topoisomerase (DNA) II alpha 170 kDa Enzyme -156.1 1.74E-20